In this article, we catch up with the past. Just to make sure that we have everyone on the same virtual page. Acomplia (generic name rimonabant) has been an authorised medication in the EU since June 2006 for use in …

At the American College of Cardiology Scientific Sessions in New Orleans, investigators presented details of their studies with rimonabant (trade name: Acomplia) - the first of a new class of drugs (selective CB1 blockers) aimed at helping with weight loss …

Crave for food and cigarette are two unhealthy urges. They lead you to path of inheriting various diseases. Such detrimental habits if not controlled can lead the mankind to disastrous consequences. Medical science has found a medication to control both …

More and more people are turning to pharmaceutical solutions to help them fight chronic weight and obesity problems. While we would all like to be able to control our weight through diet and exercise, many in our society find that …

If your excess body weight has a negative impact on your confidence, it can make you feel left out and discouraged. If you have the desire to make a change and get your body back into shape, but have found …

Rimonabant is a new diet pill manufactured by Sanofi Aventis and is approved for sale in European union since the summer of 2006. Rimonabant is a oral prescription weight loss drug helps to treat obesity for the people have BMI …

Acomplia works by selectively targeting and blocking the CB1 receptors,  helping normalize the over-activation of the EC system and making hunger or cigarette pangs more manageable.

Acomplia is a new anti-obesity drug, developed by Sanofi-Aventis, a french pharmaceutical company. If you …

The new diet pill Rimonabant is generating great interest among the overweight patients on this pretext. Proven records are also available related to its success on obesity.

Apart for keeping a person free from excess weight, the diet pill Rimonabant also …

When Rimonabant, the wonder weight loss drug, hits the market, it will have a gigantic mission to complete- the mission to cure obesity in a 200 million strong population around the world. The mission at hand of Rimonabant is a …

In clinical trials conducted over a year a third of obese patients that took the drug lost 10% of their body weight, while two thirds lost over 5% of their body weight. These successful results suggest this remarkable new product …